Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer
Kanika Singh, Nazim Nassar, Ava Bachari, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4107-4107
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The Transdermal Delivery of Therapeutic Cannabinoids
Haleh Mahmoudinoodezh, Srinivasa Reddy Telukutla, Sukhvir Kaur Bhangu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 438-438
Open Access | Times Cited: 39
Nanoformulations as a strategy to overcome the delivery limitations of cannabinoids
T. Srinivasa Reddy, Roby Zomer, Nitin Mantri
Phytotherapy Research (2023) Vol. 37, Iss. 4, pp. 1526-1538
Open Access | Times Cited: 39
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer
Alì Mokhtar Mahmoud, Magdalena Kostrzewa, Viviana Marolda, et al.
Pharmacological Research (2023) Vol. 189, pp. 106683-106683
Open Access | Times Cited: 27
Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment
Herman J. Woerdenbag, Peter Olinga, Ellen A. Kok, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2119-2119
Open Access | Times Cited: 17
Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations
Abdel-ilah Aziz, Long C. Nguyen, Loubna Oumeslakht, et al.
Cannabis and Cannabinoid Research (2022)
Closed Access | Times Cited: 23
Post-Harvest Operations to Generate High-Quality Medicinal Cannabis Products: A Systemic Review
H.M.S. Al Ubeed, R. B. H. Wills, Jayani Chandrapala
Molecules (2022) Vol. 27, Iss. 5, pp. 1719-1719
Open Access | Times Cited: 21
Cannabidiol and Cannabis Sativa as a potential treatment in vitro prostate cancer cells silenced with RBBp6 and PC3 xenograft
Lesetja R. Motadi, Zodwa E. Jantjies, Boitumelo Moleya
Molecular Biology Reports (2023) Vol. 50, Iss. 5, pp. 4039-4047
Open Access | Times Cited: 10
Analysis of the therapeutic basis of cannabis and its application in medicine
María Ilusión Solís Sánchez, Shirley Carolina Flores Guillen, Matías Josué Luna Mena, et al.
Salud Ciencia y Tecnología (2024) Vol. 4, pp. 937-937
Open Access | Times Cited: 3
Cannabis and cancer: unveiling the potential of a green ally in breast, colorectal, and prostate cancer
Husam ALSalamat, Sara Feras Abuarab, Hazem Mohamed Salamah, et al.
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 3
Current and Potential Use of Biologically Active Compounds Derived from Cannabis sativa L. in the Treatment of Selected Diseases
Bożena Bukowska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12738-12738
Open Access | Times Cited: 3
Molecular Mechanism of Tanshinone against Prostate Cancer
Wěi Li, Tao Huang, Shenghan Xu, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5594-5594
Open Access | Times Cited: 15
The evolution of cannabinoid receptors in cancer
Nakea M. Pennant, Cimona V. Hinton
WIREs Mechanisms of Disease (2023) Vol. 15, Iss. 4
Open Access | Times Cited: 8
Investigation of Cannabinoid Acid/Cyclodextrin Inclusion Complex for Improving Physicochemical and Biological Performance
Chulhun Park, Jieyu Zuo, Myung-Chul Gil, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2533-2533
Open Access | Times Cited: 8
The Plant Derived 3-3′-Diindolylmethane (DIM) Behaves as CB2 Receptor Agonist in Prostate Cancer Cellular Models
Paolo Tucci, Iain Brown, Guy S. Bewick, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3620-3620
Open Access | Times Cited: 7
The influence of drying and storage conditions on the volatilome and cannabinoid content of Cannabis sativa L. inflorescences
Natasha D. Spadafora, Simona Felletti, Tatiana Chenet, et al.
Analytical and Bioanalytical Chemistry (2024) Vol. 416, Iss. 16, pp. 3797-3809
Open Access | Times Cited: 2
The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer
Liuxun Li, Jiangli Xu
Clinical & Translational Oncology (2022) Vol. 25, Iss. 2, pp. 352-363
Open Access | Times Cited: 9
Cannabidiol Negatively Regulates Androgenic Signal in Prostate Cancer Cells and Fine-Tunes the Tumorigenesis by Modulating Endoplasmic Reticulum-Associated Degradation, Unfolded Protein Response, and Autophagy
Yalçın Erzurumlu, Deniz Çataklı, Serdar Sezer
Revista Brasileira de Farmacognosia (2023) Vol. 33, Iss. 2, pp. 316-325
Closed Access | Times Cited: 4
Development and Characterization of a Microemulsion Con-taining a Cannabidiol Oil and a Hydrophilic Extract from Sambucus ebulus for Topical Administration
Teresa Areses-Huete, Damián Córdoba-Díaz, Ana Isabel Torres‐Suárez, et al.
(2024)
Open Access | Times Cited: 1
Development and Characterization of a Microemulsion Containing a Cannabidiol Oil and a Hydrophilic Extract from Sambucus ebulus for Topical Administration
Teresa Areses-Huete, Damián Córdoba-Díaz, Ana Isabel Torres‐Suárez, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 705-705
Open Access | Times Cited: 1
An overview of phytochemical constituents and pharmacological implications of Cannabis sativa L.
Shubh Pravat Singh Yadav, Monika Kafle, Netra Prasad Ghimire, et al.
Journal of Herbal Medicine (2023) Vol. 42, pp. 100798-100798
Closed Access | Times Cited: 2
Rationalizing a prospective coupling effect of cannabinoids with the current pharmacotherapy for melanoma treatment
Ava Bachari, Nazim Nassar, Ellen Schanknecht, et al.
WIREs Mechanisms of Disease (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Treatment of malignant diseases with phytocannabinoids: promising observations in animal models and patients
Gerhard Nahler
Exploration of Medicine (2023), pp. 847-877
Open Access | Times Cited: 2
Bioengineering of Cannabis Plants from Lab to the Field: Challenges and Opportunities
Farag Sayed, Wolfgang Eisenreich
Concepts and strategies in plant sciences (2024), pp. 649-695
Closed Access
Synthesis, In Vitro Biological Evaluation of Antiproliferative and Neuroprotective Effects and In Silico Studies of Novel 16E-Arylidene-5α,6α-epoxyepiandrosterone Derivatives
Vanessa Brito, Mariana Marques, Marta Esteves, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 812-812
Open Access | Times Cited: 1
Cannabinoids and Cancer
Marco Falasca, Mauro Maccarrone
Cancers (2021) Vol. 13, Iss. 17, pp. 4458-4458
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top